Intellia Therapeutics (NTLA) Capital Expenditures (2015 - 2026)
Intellia Therapeutics (NTLA) reported Capital Expenditures of $1.81 million for Q2 2026, up 656.9% from $239,000 a year earlier.
Powered by 
Analysis
Intellia Therapeutics (NTLA) Capital Expenditures (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Intellia Therapeutics' Capital Expenditures came in at $2.04 million, down 36.8% year-over-year; for FY2025, it came in at $1.13 million, down 80.5% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -20.6% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $5.78 million in FY2024 (-58.7%), $13.99 million in FY2023 (+3.1%), $13.56 million in FY2022 (+6.3%) and $12.76 million in FY2021 (+255.8%).
- The Q2 2026 figure ranks as the highest quarterly Capital Expenditures since Q1 2024.
- Year over year, Capital Expenditures gained in 1 of the last eight quarters, with growth averaging 16.2%.
- The high point for year-over-year Capital Expenditures in five years was Q2 2026 (growth of 656.9%); the low point was Q3 2025 (a decline of 97.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $79,000 (Q1 2026), $126,000 (Q4 2025) and $29,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Intellia Therapeutics | 1.68 Bn | 1.68 Bn | - | 1.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 126,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 735,000.00 |
| Dec 31, 2024 | 981,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 4.33 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 3.83 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Sep 30, 2021 | 4.54 Mn |
API Access
Intellia Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NTLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NTLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NTLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();